Navigating the procurement of synthetic bioregulatory peptides requires strict adherence to analytical purity, supply chain transparency, and documented lot consistency. PX1 Research provides laboratory-grade Cortagen designed exclusively for in vitro experimentation, cell culture assays, and preclinical neurobiological research.
Navigating the procurement of synthetic bioregulatory peptides requires strict adherence to analytical purity, supply chain transparency, and documented lot consistency. PX1 Research provides laboratory-grade Cortagen designed exclusively for in vitro experimentation, cell culture assays, and preclinical neurobiological research.
When evaluating a supplier to buy neuroprotective agent Cortagen for laboratory research, principal investigators require high-purity reference materials supported by transparent, lot-specific analytical documentation. Sourcing Cortagen (Ala-Glu-Asp-Pro) demands verified High-Performance Liquid Chromatography (HPLC) purity, Mass Spectrometry (MS) identity verification, low endotoxin thresholds, and compliant US manufacturing to ensure reliable, reproducible experimental outcomes in preclinical neuronal and gene expression models.
PX1 Research serves the global scientific community by manufacturing and distributing high-purity peptides under rigorous quality assurance protocols. Every batch of Cortagen peptide undergoes comprehensive independent validation at ISO 17025 accredited testing facilities, delivering the analytical rigor necessary for sophisticated benchtop assays.
Cortagen is a synthetic tetrapeptide with the primary amino acid sequence L-alanyl-L-glutamyl-L-aspartyl-L-proline (Ala-Glu-Asp-Pro). Categorized structurally within the short peptide bioregulator family originally characterized in peptide gerontology research, Cortagen was developed as a targeted synthetic analogue of complex brain-derived polypeptide fractions.
Preclinical studies suggest that short bioregulatory peptides modulate nuclear chromatin organization and gene expression by binding to specific DNA motif sequences in the promoter regions of target genes. In vitro assays demonstrate that Cortagen interacts directly with histone-DNA complexes, altering nucleosome accessibility and subsequently influencing transcription factors linked to neuronal survival, differentiation, and cellular stress responses.
In vitro data indicate that Cortagen exhibits neuroprotective potential across several models of acute metabolic disruption and oxidative stress. Researchers evaluating ischemic injuries in murine neuronal cell cultures observed that Cortagen administration attenuated apoptotic cascades, reduced reactive oxygen species (ROS) accumulation, and supported structural cell viability following oxygen-glucose deprivation (OGD).
Furthermore, animal models investigating traumatic brain injury and peripheral nerve transection have demonstrated that Cortagen application correlates with accelerated functional recovery and enhanced expression of nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF). These observations suggest that Cortagen's primary mechanism involves the upregulation of endogenous neurotrophic pathways rather than direct receptor agonism, making it a valuable target in neurodegenerative research.
Beyond immediate neuroprotection against ischemic shock, Cortagen's influence on mRNA expression profiles forms a major focus of modern molecular biology research. Genomic profiling of treated primary cortical neurons indicates selective upregulation of genes encoding antioxidant enzymes, including superoxide dismutase (SOD) and catalase.
Simultaneously, in vitro research suggests Cortagen downregulates pro-inflammatory cytokines such as interleukin-1 beta (IL-1β) and tumor necrosis factor-alpha (TNF-α) in activated microglial cell lines. This dual regulatory capability—promoting endogenous antioxidant defense while modulating neuroinflammatory signal transduction—makes Cortagen a critical tool for exploring chromatin-mediated gene activation.
To properly contextualize Cortagen within neurobiological investigations, researchers often contrast its structural and operational profile against other short-chain neuropeptides and bioregulators available in the PX1 Research catalogue.
While Cortagen (Ala-Glu-Asp-Pro) specifically targets epigenetic chromatin remodeling and neurotrophic factor expression in central nervous system models, Pinealon peptide (Glu-Asp-Arg) operates as a distinct tripeptide focused heavily on mitochondrial membrane stabilization and circadian rhythm-regulated neuronal survival. Conversely, synthetic neuropeptides such as Semax and Selank are heptapeptides derived from ACTH and Tuftsin respectively, working primarily through neuromodulatory receptor pathways, BDNF signaling, and monoaminergic neurotransmission. Researchers frequently utilize these comparative profiles to design multi-peptide assay panels in comparative neuroprotective screening.
Procuring research compounds from an unverified vendor introduces high risks of baseline experimental variance, culture contamination, and irreproducible quantitative data. When evaluating a supplier for Cortagen, academic and industrial laboratories must demand strict compliance with technical specifications:
1. **Purity Level Verification:** Analytical assays must confirm a peptide purity of ≥98.0% by RP-HPLC, ensuring that synthesis side-products, truncated sequences, and residual protecting groups do not interfere with assay readouts. 2. **Mass Spectrometry Validation:** Electrospray Ionization Mass Spectrometry (ESI-MS) or MALDI-TOF mass spectra must match the theoretical molecular weight of Cortagen (444.44 g/mol) to verify structural identity. 3. **Endotoxin Quantification:** Bacterial endotoxins (lipopolysaccharides) can cause false-positive inflammatory responses in cell culture models. Suppliers must provide kinetic Chromogenic LAL assay data showing endotoxin levels below 0.1 EU/mg. 4. **Batch Traceability & Domestic Manufacturing:** Synthesizing compounds within cGMP-compliant US facilities under ISO 9001:2015 and ISO 17025 standards ensures batch-to-batch consistency and raw material safety.
PX1 Research publishes a comprehensive Certificate of Analysis (COA) for every batch of Cortagen offered. Researchers can cross-examine published analytical reports against their in-house quality control parameters prior to experimental integration.
A valid COA must detail the precise HPLC retention time, peak area percentage integration, observed mass vs. calculated mass, moisture content analysis (Karl Fischer titration), and residual solvent analysis (GC-MS). By maintaining complete transparency in our PX1 Research library, investigators can rely on uniform concentration curves and stable baseline control values.
Cortagen is supplied as a lyophilized (freeze-dried) cake or powder to preserve peptide bond integrity during storage and transit. Proper laboratory handling procedures are mandatory to prevent degradation prior to assay execution:
**Lyophilized Storage:** Upon receipt, sealed vials containing lyophilized Cortagen should be stored at -20°C for short-to-medium term storage, or at -80°C for long-term preservation. Vials should be kept away from intense light and moisture. **Reconstitution Protocol:** Prior to opening, allow the vial to equilibrate to room temperature to prevent condensation of atmospheric moisture onto the desiccated powder. Reconstitute using sterile, bacteriostatic water or sterile phosphate-buffered saline (PBS, pH 7.4), depending on assay requirements. Gentle swirling is recommended; avoid vigorous vortexing or sonication, which can cause mechanical shear stress. **Reconstituted Stability:** Once solubilized, aliquoting into single-use working volumes is recommended to avoid destructive freeze-thaw cycles. Liquid aliquots should be maintained at -20°C or colder and utilized within designated laboratory stability limits.
PX1 Research accommodates the needs of individual research labs as well as large-scale institutional projects requiring bulk quantities. Our logistics infrastructure ensures fast processing, with same-day dispatch available Monday through Friday from our centralized shipping hubs in California and Arizona.
Principal investigators, contract research organizations (CROs), and university facilities requiring customized synthesis volumes, specialized vial configurations, or recurring supply schedules are invited to establish an account via our wholesale procurement portal. All shipments are packed with thermal insulation to safeguard structural stability throughout transit.
What is the sequence and molecular weight of Cortagen?
Cortagen is a synthetic tetrapeptide with the amino acid sequence Ala-Glu-Asp-Pro (L-alanyl-L-glutamyl-L-aspartyl-L-proline). It has a theoretical molecular weight of approximately 444.44 g/mol.
What preclinical models are primarily used to study Cortagen?
Cortagen is studied in vitro using primary neuronal cell cultures, microglial lines, and brain slice preparations, as well as in rodent models of focal cerebral ischemia, peripheral nerve crush injuries, and age-related neurodegeneration.
How is PX1 Research Cortagen tested for quality and purity?
Every lot of Cortagen undergoes third-party verification at ISO 17025 accredited laboratories using Reverse-Phase HPLC for purity (≥98%), ESI-MS for structural identity, and LAL assays for endotoxin quantification.
Is Cortagen approved for human administration or therapeutic use?
No. Cortagen is sold strictly as a research compound intended solely for in vitro, cell culture, and laboratory experimentation. It is not for human or animal consumption, medical treatment, diagnosis, or clinical use.
What solvent is recommended for reconstituting Cortagen in cell culture assays?
Cortagen is highly water-soluble. Reconstitution is typically performed using sterile laboratory-grade water, sterile normal saline, or sterile phosphate-buffered saline (PBS, pH 7.4) under a laminar flow hood.
Why is endotoxin testing critical for research peptides like Cortagen?
Endotoxins (LPS) can stimulate immune responses in cultured microglial cells and primary neurons, introducing compounding inflammatory variables that invalidate experimental readouts. Low endotoxin levels (<0.1 EU/mg) ensure assay accuracy.
How does Cortagen compare structurally to Pinealon?
Cortagen is a tetrapeptide (Ala-Glu-Asp-Pro) targeting epigenetic gene expression in central nervous tissue, whereas Pinealon is a tripeptide (Glu-Asp-Arg) heavily studied for mitochondrial protection and ROS suppression.
Where does PX1 Research ship Cortagen from?
PX1 Research manufactures and inventories products in the United States, dispatching research shipments same-day (Monday through Friday) from warehouse locations in California and Arizona.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.